From being named by our employees as a Great Place to Work™, to the creation of our tests that transform cancer care, we strive to foster an innovative, inclusive environment. We thank our employees for the valuable feedback and continue to look for ways to improve and ensure all belong at Exact Sciences.
Cancer is the second largest cause of mortality in Europe each year. We want to change that. By advancing cancer care for patients at all stages of the disease, we are working to redefine the way we think about diagnosing and treating cancer.
Prostate cancer is common in men, but how much do you know about this disease? Learn the basics about prostate cancer in this article via our partner Katie Couric Media: http://ms.spr.ly/6040Xzu68
Our Oncotype DX Breast Recurrence Score® test is now reimbursed in Italy. We’re proud of our team’s progress in making personalized treatment guidance more accessible worldwide. Read more about our test: http://ms.spr.ly/6045X1PRN
Free Virtual Event (8/13): Ana Hooker, our SVP of Operations, will join a panel of biotech leaders to share insights from scaling up our operations in Madison, WI. Visit The Forward Festival to register: http://ms.spr.ly/6045nvpvN
Attending routine cancer screenings is important, but what happens when the nearest hospital is hundreds of miles away? This is the reality for many Alaska Natives. Learn more about how remote communities are still finding ways to get screened in this article with our partner Katie Couric Media. http://ms.spr.ly/6042n57xC
We are honored to be certified as a Great Place to Work™ for the third year in a row. Watch this video to see what makes Exact Sciences great.
Dr. Bert Vogelstein’s vision for the future of screening inspires our work every day to advance our multi-cancer earlier detection blood test.
We are proud our team’s feedback placed us on Energage and Wisconsin State Journal's 2021 list of Top Workplaces in our home state of Wisconsin.
A colon cancer diagnosis often leads patients to search for information that will help them and their doctor make smart treatment decisions. This CRC Awareness Month, we're highlighting how the Oncotype DX Colon Recurrence Score ®Test can help inform these critical decisions.
